Moore RD - Search Results

1

Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.

Gebo KA, Diener-West M, Moore RD. Gebo KA, et al. Among authors: moore rd. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):143-52. doi: 10.1097/00126334-200106010-00009. J Acquir Immune Defic Syndr. 2001. PMID: 11404536

2

Race, sex, drug use, and progression of human immunodeficiency virus disease.

Chaisson RE, Keruly JC, Moore RD. Chaisson RE, et al. Among authors: moore rd. N Engl J Med. 1995 Sep 21;333(12):751-6. doi: 10.1056/NEJM199509213331202. N Engl J Med. 1995. PMID: 7643881 Free article.

3

Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy.

Fortgang IS, Belitsos PC, Chaisson RE, Moore RD. Fortgang IS, et al. Among authors: moore rd. Am J Gastroenterol. 1995 Sep;90(9):1433-6. Am J Gastroenterol. 1995. PMID: 7661164

4

Hospital admissions of HIV-infected patients from 1988 to 1992 in Maryland.

Fortgang IS, Moore RD. Fortgang IS, et al. Among authors: moore rd. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):365-72. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882101

5

Functional status of persons with HIV infection in an ambulatory setting.

Stanton DL, Wu AW, Moore RD, Rucker SC, Piazza MP, Abrams JE, Chaisson RE. Stanton DL, et al. Among authors: moore rd. J Acquir Immune Defic Syndr (1988). 1994 Oct;7(10):1050-6. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8083822

6

Racial differences in the use of drug therapy for HIV disease in an urban community.

Moore RD, Stanton D, Gopalan R, Chaisson RE. Moore RD, et al. N Engl J Med. 1994 Mar 17;330(11):763-8. doi: 10.1056/NEJM199403173301107. N Engl J Med. 1994. PMID: 8107743 Free article.

7

Zidovudine therapy and health resource utilization in AIDS.

Moore RD, Hidalgo J, Bareta JC, Chaisson RE. Moore RD, et al. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):349-54. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8133446

8

Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.

Gebo KA, Moore RD, Keruly JC, Chaisson RE. Gebo KA, et al. Among authors: moore rd. J Infect Dis. 1996 Apr;173(4):857-62. doi: 10.1093/infdis/173.4.857. J Infect Dis. 1996. PMID: 8603963

9

Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection.

Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Chaisson RE, et al. Among authors: moore rd. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 15;11(5):455-9. doi: 10.1097/00042560-199604150-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8605590

10

Natural history of opportunistic disease in an HIV-infected urban clinical cohort.

Moore RD, Chaisson RE. Moore RD, et al. Ann Intern Med. 1996 Apr 1;124(7):633-42. doi: 10.7326/0003-4819-124-7-199604010-00003. Ann Intern Med. 1996. PMID: 8607591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

930 results

Search Page

Filters